Insider · CIK 0001214476
Hartoun Hartounian
Files at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). First filing -, latest -.
In brief
Hartoun Hartounian files SEC Form 4 as COO and director at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hartoun Hartounian has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.70 | $158k | 225,000 | May 20, 2026 |
| Jan 1, 2025 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 52,000 | Jan 3, 2025 |
Questions about Hartoun Hartounian
Answered from the filings on this page, as of the latest one.
Is Hartoun Hartounian buying or selling?
Hartoun Hartounian has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hartoun Hartounian's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hartoun Hartounian has 0.
Where does Hartoun Hartounian file Form 4?
Hartoun Hartounian has filed Form 4 at BCLI (BRAINSTORM CELL THERAPEUTICS INC.) as EVP, Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.